EDAP TMS S A : June 4th, 2024 Form 6 K - MarketScreener
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT...
Source: marketscreener.com
📰 Breakthrough Device News
Breakthrough Device News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Breakthrough Device. Real-time updates on events, politics, business and more.
EDAP TMS S A : Reports First Quarter 2024 Financial Results - Form 6-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...
Source: marketscreener.com
Toku welcomes Dr Robert Weinreb to Board of Directors
SAN DIEGO--(BUSINESS WIRE)--May 3, 2024--
Source: joplinglobe.com
The Long, Controversial Search for a 'Cancer Microbiome'
Conflicting research and divisive logic dominate the quest to answer a critical question: Do cancer tumors have their own microbiomes, and what would that mean for an eventual cure?
Source: medscape.com
Fujifilm Introduces First-of-its-Kind Transducer for On-Pump Intracardiac Echocardiography Imaging (OPIE) for Septal Myectomy
Provides real-time visualization and guidance for measuring ventricular septal thickness during septal myectomy surgery
United States Danielg Swistel Takeo Fujita Nicolas Smedira Hideyuki Honda American Association For Thoracic Surgery
Source: dicardiology.com
CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Source: theweek.in
CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US
/PRNewswire/ -- Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical...
Source: prnewswire.com
CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US
TAMPA, Fla., April 20, 2024 /PRNewswire/ -- Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its
Source: thailand-business-news.com
Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368
ACR-2316, which was internally discovered using biological SAR enabled by AP3 to overcome limitations of benchmark clinical WEE1 and PKMYT1 inhibitors, demonstrates potent anticancer activity in...
United States Alexandra Santos Peter Blume Jensen Exchange Commission Drug Administration Acrivon Therapeutics Inc
Source: marketscreener.com
Acrivon Therapeutics Announces $130 Million Private Placement Financing
WATERTOWN, Mass, April 09, 2024 -- Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are...
United States Peter Blume Jensen Alexandra Santos Drug Administration Exchange Commission Acrivon Therapeutics Inc
Source: marketscreener.com